The mass array method allows for the simultaneous analysis of multiple genetic polymorphisms.
There are individual differences in drug metabolism activity, and these differences are believed to be due to genetic polymorphisms. In the field of pharmacogenomics (PGx), there is an expectation for the application of personalized medicine that takes into account the effects of drugs, side effects, and drug interactions by investigating genetic polymorphisms. This document introduces the analysis of genetic polymorphisms related to drug metabolism using a designed analysis tool based on mass array methods. Genetic polymorphisms will be determined from the analysis results of SNPs (Single Nucleotide Polymorphisms) and CNVs (Copy Number Variations) for 20 drug metabolism-related genes.
Inquire About This Product
basic information
For more details, please download the materials or contact us.
Price range
Delivery Time
Applications/Examples of results
Biotechnology, analysis of pharmaceuticals.
catalog（1）
Download All Catalogs
Company information
MST is a foundation that provides contract analysis services. We possess various analytical instruments such as TEM, SIMS, and XRD to meet your analysis needs. Our knowledgeable sales representatives will propose appropriate analysis plans. We are also available for consultations at your company, of course. We have obtained ISO 9001 and ISO 27001 certifications. Please feel free to consult us for product development, identifying causes of defects, and patent investigations! MST will guide you to solutions for your "troubles"!
